Introduction {#s1}
============

Head and neck neoplasms are the sixth leading cause of death by cancer [@pone.0047579-Walker1]. The most common histological type is the squamous cell carcinoma, accounting for about 90% of all cases [@pone.0047579-Casiglia1], [@pone.0047579-Reichart1]. Being a multifactorial disease, the etiology of head and neck squamous cell carcinoma (HNSCC) is still a much debated question. Smoking of cigarettes, consumption of alcohol and genetic causes are some of the foci of former etiological studies.

Enzymes of the glutathione S-transferase (GST) family are present in eukaryotes and in prokaryotes, which are composed of many cytosolic, mitochondrial, and microsomal proteins. They catalyze various reactions and participate in the phase II biotransformation of xenobiotics. GSTs contribute to the detoxification of by-products of smoking and alcohol and other exogenous chemical carcinogens which may induce HNSCC, so they have been considered as potential candidates for HNSCC susceptibility. Classes*ι* and *μ* of the GST superfamily have been paid lots of attention, which are encoded by *GSTT1* and *GSTM1* genes. The *GSTM1* and *GSTT1* gene have been localized to chromosome 1p13.3 and 22q11.2. Both of the genes are polymorphic and frequent homozygous deletions of the genes presenting null genotype are associated with loss of the corresponding enzyme activity. Therefore, carriers with null genotype will increase the risk of the development of HNSCC due to the decreased ability to detoxify carcinogens theoretically.

In 2003, a meta-analysis conducted by Hashibe *et al.* indicated modest associations of *GSTM1* and *GSTT1* genotypes with head and neck cancer risk [@pone.0047579-Hashibe1]. However, more than twenty independent studies from various populations have further examined the relationships between these two genes and HNSCC risk, and still reported conflicting results. Some studies in HNSCC have indicated that the null genotype of *GSTM1* or *GSTT1* is a risk factor of HNSCC development [@pone.0047579-Ruwali1]--[@pone.0047579-Singh1]. However, such an association was not observed in some other groups [@pone.0047579-Suzen1]--[@pone.0047579-Biselli1]. Therefore, it is necessary to reevaluate the association of *GSTM1* or *GSTT1* null genotype with the risk of HNSCC by pooling the new published studies using meta-analysis. The present study included all eligible published case-control studies to establish a relatively comprehensive picture of the relationship between these two genes and HNSCC.

Materials and Methods {#s2}
=====================

Selection criteria and identification of eligible studies {#s2a}
---------------------------------------------------------

Candidate studies were identified through computer-aided literature searches in PubMed for relevant articles in English and Chinese (1995 to May 2012). To identify all articles that studied the association of *GSTT1* and *GSTM1* polymorphisms with HNSCC, we conducted the search using the following keywords and subject terms: 'GSTT1' or 'GSTM1', and 'squamous'. We also searched the references cited in the articles and included published works. Abstracts, case-only articles, editorials, review articles and repeated literatures were excluded. Of the articles with the overlapping data, we only included the publication with the most extensive information. The inclusion criteria in the current meta-analysis were as follows: (a) they are unrelated studies; (b) identification of squamous cell carcinoma was histologically confirmed; and (c) they have original data of genotype frequency and provided sufficient information to calculate the odds ratio (OR) or P-value.

Data extraction {#s2b}
---------------

Two reviewers (Zhang Y and Ni Y) independently examined the studies for inclusion in the meta-analysis and collected data on the genotype of *GSTT1* and *GSTM1*. We extracted the following information from each study: first author, year of publication, country, ethnicity, numbers of case and control, smoking status and genotyping information. Disagreements between two reviewers were discussed and resolved with consensus. When essential information was not found in articles, we made effort to get the data from the authors ([Figure 1](#pone-0047579-g001){ref-type="fig"}).

![Flow diagram of study identification.](pone.0047579.g001){#pone-0047579-g001}

Statistical analysis {#s2c}
--------------------

The meta-analysis for *GSTM1* or *GSTT1* null genotype or dual null genotype compared HNSCC vs. controls. Odds ratio (OR) and its 95% confidence interval (CI) were assessed for each study. The Cochran\'s Q-statistic was used to test heterogeneity, and the heterogeneity was considered statistically significant when *P*\<0.1 [@pone.0047579-Zintzaras1]. The Mantel-Haenszel method was used to calculate the OR for the included data in a fixed effects model in the absence of between-study heterogeneity, while random effects model was used for those with heterogeneity. P-value\<0.05 was considered statistically significant, and 0.05≤P-value\<0.10 was indicated suggestive. In addition, we also performed stratification analyses on ethnicity, smoking and combined analyses of *GSTM1* and *GSTT1* on HNSCC risk. The sensitivity analysis was carried out to test the stability of the pooled effect after excluding individual studies. Begg\'s funnel plot was used to evaluate publication bias. All above statistical analysis was carried out using the software packages Review Manager (RevMan) 5.1.

Results {#s3}
=======

Eligible studies and meta-analysis databases {#s3a}
--------------------------------------------

We identified 221 articles through the initial computerized search of published work. After reading titles, abstracts, 55 articles were retained. For the analysis of *GSTM1* or *GSTT1*, after discarding 11 articles [@pone.0047579-Singh1], [@pone.0047579-Trizna1]--[@pone.0047579-Jahnke1] due to the overlapping data and 1 article [@pone.0047579-Olivieri1] due to lack of essential genotype information, 44 case-control studies [@pone.0047579-Ruwali1], [@pone.0047579-Loureno1], [@pone.0047579-Suzen1]--[@pone.0047579-Biselli1], [@pone.0047579-Jahnke2]--[@pone.0047579-Shukla1] finally met our criteria for inclusion. Among them, 42 studies described the association between *GSTM1* null genotype and HNSCC, and 32 between *GSTT1* null genotype and HNSCC. For the association between dual null genotype and HNSCC, 1 discarded article [@pone.0047579-OudeOphuis1] containing the distribution information of dual null genotype was reincorporated, and 15 studies were included ([Table 1](#pone-0047579-t001){ref-type="table"}). For the analyses stratified by smoking, eight studies [@pone.0047579-Ruwali1], [@pone.0047579-Suzen1], [@pone.0047579-NazarStewart1], [@pone.0047579-Olshan1], [@pone.0047579-Peters1], [@pone.0047579-Sugimura1], [@pone.0047579-Anantharaman1], [@pone.0047579-Li2] for *GSTM1*, and seven studies [@pone.0047579-Ruwali1], [@pone.0047579-Olshan1], [@pone.0047579-Evans1], [@pone.0047579-Peters1]--[@pone.0047579-Anantharaman1] for *GSTT1* were included.

10.1371/journal.pone.0047579.t001

###### Characteristics of studies included in meta-analysis.

![](pone.0047579.t001){#pone-0047579-t001-1}

  Author (Ref)                     Year     Country       Ethnicity      Case   Control   Whether has genotype distribution information                    
  ------------------------------- ------ ------------- ---------------- ------ --------- ----------------------------------------------- ----------- ----- -----
  Jahnke et al. (23)               1996     Germany        European      269      216                          Yes                           Yes      No    No
  Park et al. (24)                 1997       USA          European      133      133                          Yes                           No       No    No
  González et al. (25)             1998      Spain         European       75      200                          Yes                           No       No    No
  Oude Ophuis et al. (13)          1998   Netherlands      European      185      207                       Discarded                     Discarded   Yes   No
  Cheng et al. (26)                1999       USA          European      162      315                          Yes                           Yes      Yes   No
  Katoh et al. (27)                1999      Japan          Asian         92      147                          Yes                           Yes      No    No
  Morita et al. (28)               1999      Japan          Asian        145      164                          Yes                           No       No    No
  Nazar-Stewart et al. (29)        1999       USA          European       48      144                          Yes                           No       No    Yes
  Sato et al. (30)                 1999      Japan          Asian        142      142                          Yes                           No       No    No
  Tanimoto et al. (31)             1999      Japan          Asian        100      100                          Yes                           No       No    No
  Hamel et al. (32)                2000     Canada         European       90      90                           Yes                           Yes      No    No
  Olshan et al. (33)               2000       USA          European      182      202                          Yes                           Yes      No    Yes
  Hahn et al. (34)                 2002     Germany        European       94      92                           Yes                           No       No    No
  To-Figureras et al. (35)         2002      Spain         European      204      203                          Yes                           Yes      No    No
  Gronau et al. (36)               2003     Germany        European      187      139                          Yes                           Yes      Yes   No
  Drummond et al. (37)             2004     Brazil      South American    70      82                           Yes                           No       No    No
  Evans et al. (38)                2004       USA          European      283      208                          Yes                           Yes      No    Yes
  Li et al. (39)                   2004      China          Asian         89      164                          Yes                           No       No    No
  Drummond et al. (40)             2005     Brazil      South American    87      81                           No                            Yes      No    No
  Gajecka et al. (41)              2005     Poland         European      292      321                          Yes                           Yes      No    No
  Acar et al. (42)                 2006     Turkey          Asian        110      197                          Yes                           Yes      No    No
  Biselli et al. (10)              2006     Brazil      South American    60      60                           Yes                           Yes      Yes   No
  Gatta\'s et al. (43)             2006     Brazil      South American   103      102                          Yes                           Yes      Yes   No
  Oude Ophuis et al. (44)          2006   Netherlands      European      185      285                          Yes                           Yes      No    No
  Peters et al. (45)               2006       USA          European      692      753                          Yes                           Yes      No    Yes
  Sharma et al. (46)               2006      India          Asian         40      87                           Yes                           Yes      No    Yes
  Sugimura et al. (47)             2006      Japan          Asian        122      241                          Yes                           Yes      No    Yes
  Anatharaman et al. (48)          2007      India          Asian        451      727                          Yes                           Yes      No    Yes
  Cha et al. (49)                  2007      Korea          Asian         72      209                          Yes                           No       No    Yes
  Suzen et al. (8)                 2007     Turkey          Asian         98      120                          Yes                           Yes      Yes   Yes
  Boccia et al. (9)                2008      Italy         European      210      245                          Yes                           Yes      No    No
  Buch et al. (50)                 2008       USA          European      196      414                          Yes                           Yes      No    No
  Harth et al. (51)                2008     Germany        European      312      300                          Yes                           Yes      No    No
  Hatagima et al. (52)             2008     Brazil      South American   231      212                          Yes                           Yes      No    No
  Losi-Guembarovski et al. (53)    2008     Brazil      South American    91      81                           Yes                           Yes      No    No
  Amtha et al. (54)                2009    Indonesia        Asian         81      162                          Yes                           Yes      No    No
  Li et al. (55)                   2009      China          Asian         76      76                           Yes                           Yes      No    Yes
  Chatzimichalis et al. (56)       2010      Greek         European       88      102                          Yes                           Yes      No    No
  Leme et al. (57)                 2010     Brazil      South American   100      100                          Yes                           Yes      Yes   No
  Sam et al. (58)                  2010      India          Asian        408      220                          Yes                           Yes      Yes   No
  Soucek et al. (59)               2010      Czech         European      122      179                          Yes                           Yes      No    No
  Lourenço et al. (6)              2011     Brazil      South American   142      142                          Yes                           Yes      No    No
  Ruwali et al. (5)                2011      India          Asian        500      500                          Yes                           Yes      Yes   Yes
  Shukla et al. (60)               2012      India          Asian        150      141                          Yes                           No       No    No

Heterogeneity result {#s3b}
--------------------

Cochran\'s Q tests indicated heterogeneity exist in different studies in the analysis except studies of dual genes in South American (*P* = 0.51, I^2^ = 0%) and *GSTM1* in non-smokers (*P* = 0.65, I^2^ = 0%). The random or fixed effect model was selected for comparisons with or without heterogeneity, respectively.

Meta-analysis results {#s3c}
---------------------

A total of 7584 HNSCC cases and 8576 controls for *GSTM1*, 6255 cases and 7138 controls for *GSTT1*, 2657 cases and 3092 controls for dual genes were investigated.

For *GSTM1* polymorphism, the overall meta-analysis showed a suggestively increased risk in null genotype as compared to wild genotype (OR = 1.145, 95% CI: 1.00--1.29, *P* = 0.05) ([Figure 2](#pone-0047579-g002){ref-type="fig"}). In sensitivity analysis by temporarily excluding individual studies, no single study substantially affected the pooled OR, indicating that the results of these meta-analyses are stable. Analysis after stratification by ethnicity indicated *GSTM1* null genotype tended to be associated with HNSCC in Asian (OR = 1.48, 95% CI: 1.24--1.75, *P*\<0.01), while no significant association was found in European or South American ([Table 2](#pone-0047579-t002){ref-type="table"}).

![Forest plot of *GSTM1* associated with HNSCC under random-effects model.\
Each study is shown by point estimate of OR and 95% CI by a horizontal line. The diamond shows the overall risk and the line represent the 95% CI for each meta-analysis. Events: null genotype.](pone.0047579.g002){#pone-0047579-g002}

10.1371/journal.pone.0047579.t002

###### Genotype distribution of *GSTM1* and *GSTT1* in different Ethnicities.

![](pone.0047579.t002){#pone-0047579-t002-2}

                     *GSTM1*                       *GSTT1*                      *GSTM1*+*GSTT1*                                                                   
  ---------------- ------------ ---------------------------------------------- ----------------- ------------ ------------ ------------ ------------ ------------ ------------
  Cases (n/N^a^)    2049/4111                     1239/2676                         385/797        766/3458     497/1983     280/814       83/534      200/1769      48/354
  Controls (n/N)    2378/4475                     1361/3397                         384/779        849/3884     586/2476     205/778       57/661      185/2088      48/343
  OR^b^                0.96                          1.48                            1.05            1.21         1.32         1.63         2.01         1.56         0.96
  95% CI^c^         0.82--1.13                    1.24--1.75                      0.71--1.57      0.87--1.69   0.93--1.88   1.03--2.58   1.15--3.53   1.05--2.33   0.62--1.48
  *P* ^d^              0.64      \<0.00001[\*\*](#nt102){ref-type="table-fn"}        0.80            0.26         0.12       0.04^\*^     0.01^\*^     0.03^\*^       0.85

Abbreviations: ^a^, number of carriers with null genotype/ total number; ^b^, odds ratio; ^c^, confidence interval; ^d^, value for heterogeneity; OR, odds ratio; 95% CI, 95% confidence interval.

P \<0.01; ^\*^ 0.01≤P\<0.05

For *GSTT1* polymorphism, null genotype was associated with an increased risk of HNSCC (OR = 1.32, 95% CI: 1.07--1.64, *P* = 0.01) ([Figure 3A](#pone-0047579-g003){ref-type="fig"}). Sensitivity analysis showed that the association still exist even with exclusion of the study of Hamel et al. which was obviously deviating from others (OR = 1.21, 95% CI: 1.01--1.45, *P* = 0.04) [@pone.0047579-Hamel1] ([Figure 3B](#pone-0047579-g003){ref-type="fig"}). Analysis stratified by ethnicity indicated that *GSTT1* null genotype increased the HNSCC risk in South American (OR = 1.63, 95% CI: 1.03--2.58, *P* = 0.04) ([Table 2](#pone-0047579-t002){ref-type="table"}).

![Forest plot of *GSTT1* associated with HNSCC under random-effects model.\
A: Overall analysis. B: Sensitivity analysis with exclusion of the study by Hamel et al. 2000. The diamond shows the overall risk and the line represent the 95% CI for each meta-analysis. Events: null genotype.](pone.0047579.g003){#pone-0047579-g003}

Combined analysis of *GSTM1* and *GSTT1* on HNSCC risk showed that OR of individuals with dual null genotype was elevated (OR = 1.48, 95% CI: 1.12--1.96, *P* = 0.006) compared to *GSTM1* or *GSTT1* individual null genotype ([Figure 4](#pone-0047579-g004){ref-type="fig"}). After stratification for ethnicity, we observed a significant association for HNSCC in European (OR = 2.01, 95% CI: 1.15--3.53, *P* = 0.01) and Asian (OR = 1.56, 95% CI: 1.05--2.33, *P* = 0.03) populations among *GSTM1* and *GSTT1* dual null individuals ([Table 2](#pone-0047579-t002){ref-type="table"}). The exclusion of individual studies did not change these results qualitatively.

![Forest plot of *GSTM1* and *GSTT1* associated with HNSCC under random-effects models.\
The diamond shows the overall risk and the line represent the 95% CI for each meta-analysis. Events: null genotype.](pone.0047579.g004){#pone-0047579-g004}

We further performed stratification analysis by smoking status. As shown in [Table 3](#pone-0047579-t003){ref-type="table"}, significant association of *GSTM1* deletion with risk of HNSCC was observed in smoking group (OR = 1.51, 95% CI: 1.05--2.17, *P* = 0.03) but not in non-smoking group (OR = 1.14, 95% CI: 0.90--1.43, *P* = 0.28). However, we did not found any significant associations for *GSTT1* in either smokers (OR = 1.01, 95% CI: 0.64--1.60, *P* = 0.96) or non-smokers (OR = 1.13, 95% CI: 0.68--1.86, *P* = 0.64) ([Table 3](#pone-0047579-t003){ref-type="table"}), which may be due to the limited number of study with smoking information.

10.1371/journal.pone.0047579.t003

###### Genotype distribution of *GSTM1* and *GSTT1* in different smoking status.

![](pone.0047579.t003){#pone-0047579-t003-3}

                     *GSTM1*                   *GSTT1*                              
  ---------------- ----------- --------------------------------------- ------------ -----------
  Cases (n/N^a^)     255/455                  862/1638                    94/462     347/1671
  Controls (n/N)    473/1031                  658/1519                   222/981     325/1527
  OR^b^               1.14                      1.51                       1.13        1.01
  95% CI^c^         0.9--1.43                1.05--2.17                 0.68--1.86   0.64--1.6
  *P* ^d^             0.28      0.03[\*](#nt104){ref-type="table-fn"}      0.64        0.96

Abbreviations: ^a^, number of carriers with null genotype/total number; ^b^, odds ratio; ^c^, confidence interval; ^d^, value for heterogeneity; OR, odds ratio; 95% CI, 95% confidence interval

0.01≤P\<0.05

Publication bias {#s3d}
----------------

Funnel plots were performed to assess the publication bias, and these shapes did not suggest any obvious evidence of asymmetry in the analyses of *GSTM1*, gene-gene interaction, and *GSTT1* analysis stratified by smoking status. When one study [@pone.0047579-Hamel1] for *GSTT1* analysis and two studies [@pone.0047579-Sharma1], [@pone.0047579-Cha1] for *GSTM1* analysis stratified by smoking status were omitted, funnel plots illustrated symmetric shape.

Discussion {#s4}
==========

Genetic factors play an important role in the etiology of tumors. For HNSCC, genes encoding xenobiotic-metabolizing enzymes (XMEs) are some of the most likely candidates that could affect individual\'s susceptibility to the disease, due to their involvement of the metabolic activation and detoxification of the environmental carcinogens [@pone.0047579-Puga1]. Conjugation is one of the most common pathways of xenobiotic metabolism and is considered phase II metabolism which is catalyzed by multiple enzyme superfamilies including Glutathione S-transferases (GSTs). GSTs mediate the reactions of glutathione with electrophiles, resulting in the elimination of potentially carcinogenic chemicals [@pone.0047579-Keen1]. *GSTM1* and *GSTT1* genes belonging to GSTs have been studied extensively due to their important detoxification function and high-frequency polymorphisms. *GSTM1* and *GSTT1* homozygous deletions (null genotype) may lead to deficient enzyme activity [@pone.0047579-Hayes1]. In the present study, the overall frequency of *GSTM1* and *GSTT1* null genotype in controls were 47.65% and 23.77% respectively in accordance with other studies [@pone.0047579-Seidegard1]--[@pone.0047579-Pemble1]. After stratification for ethnicity, the frequency of *GSTM1* and *GSTT1* null genotype in controls in European, Asian and South American were 53.14%, 40.06%, 49.29% and 21.86%, 23.67%, 26.34% respectively, which indicated ethnic differences.

The importance of *GSTM1* and *GSTT1* polymorphisms effects on HNSCC has been a concern in recent years, but the data of existing studies are contradictory. An increase in the risk of HNSCCC was observed in cases with null genotypes of *GSTM1* or *GSTT1* in some studies [@pone.0047579-Ruwali1]--[@pone.0047579-Suzen1]. However the risk was not found in other studies. For example, Boccia [@pone.0047579-Boccia1] and Biselli [@pone.0047579-Biselli1] did not find the association between *GSTM1* or *GSTT1* and HNSCC. Although the confused effect of these polymorphisms may be a result of various reasons such as demographic features of subjects and different life styles, comparatively small sample size in individual study might lead to lower statistical power and bias. The present meta-analyses of 42 studies including 7584 cases and 8651 controls for analysis of *GSTM1*, 32 studies including 6255 cases and 7138 controls for analysis of *GSTT1*, and 15 studies including 2657 cases and 3092 controls provide more comprehensive information on the relationships between two genes and HNSCC.

This meta-analysis showed that both *GSTM1* and *GSTT1* null genotype confers susceptibility to HNSCC in the overall analysis. *GSTM1* can deals with large hydrophobic electrophiles including polycyclic aromatic hydrocarbons derived epoxides (PAH) [@pone.0047579-Hayes2], [@pone.0047579-Hayes3], while *GSTT1* targets a more restricted kind of compounds, like monohalomethane and ethylene oxide [@pone.0047579-Landi1]. Different GST isoforms exhibit overlapping substrate specificity, combinations of *GSTM1* and *GSTT1* null genotype may theoretically confer a higher risk to HNSCC. Comparing to homozygous deletion of *GSTM1* and *GSTT1* alone, deletion of two genes in combination significantly increases the risk of HNSCC as showed in our combined analysis, indicating a synergenic role of *GSTT1* and *GSTM1* in cancergenesis.

Analyses after stratification by ethnicity revealed ethnicity-specific associations between two genes and HNSCC. Our findings indicate that *GSTM1* may be an important factor in Asians in the development of HNSCC, which is similar to the results reported by Hashibe et al. [@pone.0047579-Hashibe1]. However, *GSTT1* but not *GSTM1* may be important in South Americans, while *GSTM1* and *GSTT1* in combination play a vital role in Europeans and Asians. This result may be attributed to the different habits of smoking, alcohol consumption, intake of food and different genetic backgrounds in different ethnic groups.

Both *GSTT1* and *GSTM1* can prevent the accumulation of tobacco smoke carcinogens, and compared with non-smokers, mutations of these two genes theoretically increase the risk of HNSCC in smokers. To investigate potential gene-environment interaction, we stratified the data by smoking status. A significant association was observed in smokers with *GSTM1*, whereas no difference was observed between smokers and non-smokers for *GSTT1*. Previous studies showed that *GSTT1* and *GSTM1* are involved in the detoxification of carcinogens such as smoking by-products, and polymorphisms in these two genes with a result of loss of enzyme activity may increase risk of carcinogenesis and have different role in detoxification. [@pone.0047579-Hayes2]--[@pone.0047579-Landi1]. Although we found higher risk of *GSTM1* null genotype in smokers (OR = 1.51) than non-smokers (OR = 1.14), further individual large study are required to evaluate the interaction of *GSTM1* and smoking on HNSCC risk.

Although our result of this meta-analysis is constructive, its limitations and some potential bias should be addressed. First, despite that a well-designed search strategy was used to identify eligible studies, it was possible that some relevant studies were not included. This study only focused on full-text papers published in English and Chinese in PubMed, so some eligible studies in other languages or in other databases might be missed. Second, adjustments over age, gender and other environmental factors such as alcohol drinking might help better detect the association between *GSTM1*, *GSTT1* and HNSCC. If available detailed individual data are enough for an adjusted estimate in the future, a more precise analysis should be conducted. Third, ethnicity was determined roughly by subject\'s country due to inadequate available data, and this classification can help us have a regional concept of these genes functions. Fourth, the controls in the included studies were recruited in different ways and not uniformly defined, which may have distorted the meta-analysis. Finally, because all the studies were designed with retrospective studies, we cannot clearly determine the causal relationship between the risk factor and HNSCC. Given the limitations and biases above, the conclusions or interpretations made from the results of this meta-analysis should be explained with caution.

Conclusions {#s5}
===========

The results of this meta-analysis suggest that *GSTM1* and *GSTT1* null genotypes may be associated with an increased risk of HNSCC. Further large well-designed studies are warranted to confirm these findings.
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